Last reviewed · How we verify

NCT05782725

Subclinical Hypothyroidism and Normogonadotropic Anovulation

Completed Last updated 7 February 2024
What this trial tests

trial testing Comparison of laboratory test results in women in the 4 study arms in Polycystic Ovary Syndrome in 300 participants. Completed in 10 January 2024.

Timeline
1 March 2023
Primary endpoint
1 December 2023
10 January 2024

Quick facts

Lead sponsorJagiellonian University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment300
Start date1 March 2023
Primary completion1 December 2023
Estimated completion10 January 2024
Sites1 location across Poland

Drugs / interventions tested

Conditions studied

Sponsor

Jagiellonian University

Who can join

Adults 18 to 45, female only, with Polycystic Ovary Syndrome or Hypothalamic-Pituitary-Ovarian Axis Dysfunction (Disorder). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Thyroid hormones (TH) can modify the functioning of the hypothalamic-pituitary-ovarian axis, affecting the functions of granulosa cells and the development and apoptosis of preantral follicles. TH receptors are present within the oocytes, and TH and anti-thyroid antibodies (ATA) are present in the follicular fluid. Improper thyroid function can cause ovulation disorders, luteal phase failure, impaired endometrial receptivity and result in implantation failures and recurrent miscarriages. While overt hypothyroidism is treated to improve fertility, the effect of subclinical hypothyroidism (SCH) and the presence of circulating ATAs on fertility and obstetric outcomes is uncertain and data on ovarian reserve rates are conflicting. Among the causes of ovulation disorders (group II according to the WHO classification), polycystic ovary syndrome (PCOS) dominates, found in 3-15% of women of reproductive age, and the remaining group of causes is the so-called Hypothalamic-Pituitary-Ovarian Axis Dysfunction (HPOD). The exact etiology of both entities is unknown.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Polycystic Ovary Syndrome

Currently open trials in the same condition.

Other Jagiellonian University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05782725.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing